Claus Cursiefen
Corporate Officer/Principal at Cologne University of Applied Sciences
Profile
Dr. Claus Cursiefen, MD, is Chairman-Ophthalmology Department at Cologne University of Applied Sciences and an Associate Scientist at Harvard Medical School.
He is on the Board of Directors at Novaliq GmbH.
Claus Cursiefen active positions
Companies | Position | Start |
---|---|---|
Cologne University of Applied Sciences | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
Former positions of Claus Cursiefen
Companies | Position | End |
---|---|---|
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Claus Cursiefen